Surging global incidence of severe monogenic obesity disorders, expanding clinical adoptions of targeted peptide therapeutics, and continuous biopharmaceutical refinements in central nervous system receptor selectivity are driving rapid growth across the global Melanocortin Receptor 4 Market. Melanocortin receptor 4 (MC4R) therapeutic solutions—comprising peptide MC4R agonists (such as...
